Advertisement

Topics

NeuroSearch A/S Company Profile

18:38 EST 14th December 2018 | BioPortfolio

NeuroSearch is dedicated to the discovery and development of medicines to satisfy unmet medical needs. NeuroSearch’s core business focuses on diseases of the central nervous system primarily treated through modulation of ion channels and other membrane-bound transporters.

Location

Pederstrupvej 93
Ballerup
2750
Denmark

Contact

Phone: 45 4460 8000
Fax: 45 4460 8080
Email: ns@neurosearch.dk


News Articles [8 Associated News Articles listed on BioPortfolio]

NeuroSearch A/S – H1 report 2018

Announcement 30 August 2018 Below please find the H1 report 2018. The full report is available in the enclosed PDF file. NeuroSearch posted an operating loss of DKK 2.8 million in H1 2018 (H2 20...

Report on Extraordinary General Meeting of NeuroSearch A/S

Announcement14 September 2018 At the company’s Extraordinary General Meeting held today, the following resolution was passed: Morten Mathiesen and Mikkel Primdal Kæregaard were elected to the Boa...

NeuroSearch announces change to financial outlook for 2018

Company Announcement 14 August 2018 In Annual Report 2017, NeuroSearch announced a financial outlook, on a going concern assumption, of an operating loss in the range of DKK 3.5-4.5 mil...

Notice convening an Extraordinary General Meeting of NeuroSearch A/S

Company announcement 23 August 2018 Pursuant to Articles 8 and 10 of the Articles of Association, notice is hereby given of an Extraordinary General Meeting to be held on 14 September 2018, at 1...

NeuroSearch A/S receives notice of payment from Teva Pharmaceutical International GmbH regarding Pridopidine and changes financial outlook for 2018

Company Announcement 8 September 2018 On 16 May 2018, NeuroSearch A/S ("NeuroSearch") entered into an agreement with, among others, Teva Pharmaceutical International GmbH ("Teva") (the "Agreement") ...

PTV News: Feb 4th, 2010

Top stories on February 4th, 2010: Malaria breakthrough: The vaccine protecting children from killer disease Early investment – Glaxo bets on Apeiron’s phase I lung drug Ratiopharm sale "a two ho...

NeuroSearch AS NEUR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryNeuroSearch A/S NeuroSearch focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system CNS through license agreements with other ...

NeuroSearch AS NEUR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryNeuroSearch A/S NeuroSearch focuses on the development of novel pharmaceutical agents for the treatment of various disorders of central nervous system CNS through license agreements with other ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NeuroSearch A/S

NeuroSearch is dedicated to the discovery and development of medicines to satisfy unmet medical needs. NeuroSearch’s core business focuses on diseases of the central nervous system primarily treated...

More Information about "NeuroSearch A/S" on BioPortfolio

We have published hundreds of NeuroSearch A/S news stories on BioPortfolio along with dozens of NeuroSearch A/S Clinical Trials and PubMed Articles about NeuroSearch A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroSearch A/S Companies in our database. You can also find out about relevant NeuroSearch A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record